Vaccine Panel Drops Birth Dose Recommendation Without Evidence, Experts Warn of Increased Infections and Deaths.
A panel of federal vaccine advisors handpicked by anti-vaccine Health Secretary Robert F. Kennedy Jr. has voted to eliminate a recommendation that all newborn babies receive the hepatitis B vaccine on the day of birth. The decision was made with no evidence of harm from that dose and no evidence of any benefit from delaying it.
Critics of the decision say that it will lead to more infections in babies, which could result in cases of chronic liver disease, liver cancer, and premature death. Pediatrician Cody Meissner described the motivation behind the change as "baseless skepticism" and said that there was no data to support the recommendation.
The vaccine panel's vote also ignores decades of public confidence in a proven lifesaving vaccine. The American Medical Association has denounced the decision as "reckless" and urged parents to follow established guidelines for protecting their newborns from hepatitis B.
In reality, studies have shown that vaccinating all babies against hepatitis B on the day of birth is crucial in preventing infections and reducing mortality rates. Experts warn that delaying or skipping this dose increases the risk of infection, particularly among vulnerable populations such as those born to mothers who test negative for the virus or who had a false-negative result.
The decision also lacks consideration for the administrative burden and clinical feasibility of testing antibody levels after each dose, according to medical experts. Vaccine efficacy data is based on the entire three-dose series, and antibody levels are not sufficient to presume lifelong protection.
In summary, the vaccine panel's recommendation change is driven by ideology rather than science, putting millions of newborns at risk of infection and long-term health consequences.
A panel of federal vaccine advisors handpicked by anti-vaccine Health Secretary Robert F. Kennedy Jr. has voted to eliminate a recommendation that all newborn babies receive the hepatitis B vaccine on the day of birth. The decision was made with no evidence of harm from that dose and no evidence of any benefit from delaying it.
Critics of the decision say that it will lead to more infections in babies, which could result in cases of chronic liver disease, liver cancer, and premature death. Pediatrician Cody Meissner described the motivation behind the change as "baseless skepticism" and said that there was no data to support the recommendation.
The vaccine panel's vote also ignores decades of public confidence in a proven lifesaving vaccine. The American Medical Association has denounced the decision as "reckless" and urged parents to follow established guidelines for protecting their newborns from hepatitis B.
In reality, studies have shown that vaccinating all babies against hepatitis B on the day of birth is crucial in preventing infections and reducing mortality rates. Experts warn that delaying or skipping this dose increases the risk of infection, particularly among vulnerable populations such as those born to mothers who test negative for the virus or who had a false-negative result.
The decision also lacks consideration for the administrative burden and clinical feasibility of testing antibody levels after each dose, according to medical experts. Vaccine efficacy data is based on the entire three-dose series, and antibody levels are not sufficient to presume lifelong protection.
In summary, the vaccine panel's recommendation change is driven by ideology rather than science, putting millions of newborns at risk of infection and long-term health consequences.